LISBON, April 8 (Reuters) - Portugal on Thursday temporarily
suspended use of the AstraZeneca COVID-19 vaccine for
those aged under 60 amid concerns over possible links between
the shot and very rare cases of blood clots.
"I want to highlight the goal of the vaccination campaign in
Portugal is to save lives and prevent serious illness," health
authority head Graca Freitas told a news conference. "This can
be achieved with any vaccine approved in Portugal."
The coordinator of the vaccination taskforce, Henrique Melo,
said the decision to only administer AstraZeneca shots to those
under 60 would only have a "small" impact on the vaccination
rollout.
(Reporting by Catarina Demony; Editing by Nathan Allen)